The document also adds that the proposed changes by the WHO could give people the wrong idea, leading them to think that the current Schedule IV stance impedes research and that the international framework isn’t compatible with research. What they’re basically saying is that even if the United States acknowledges the benefits of reclassifying cannabis, the government is worried about how it would turn out.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…